Latest: Osimertinib/osimertinib launch price changes in 2024

Osimertinib (Osimertinib) is an oral targeted therapy drug, mainly used to treat EGFR (epidermal growth factor receptor) gene mutation-positive advanced non-small cell lung cancer (NSCLC). As a third-generation EGFRtyrosine kinase inhibitor, osimertinib/osimertinibhas the ability to target EGFR< High selectivity for sensitive mutations such as Del19 and L858R, as well as drug-resistant mutations such as T790M.

Currently, the original drug of osimertinib/osimertinib has been launched in the domestic market and has been included in my country’s medical insurance system. Patients can easily purchase it domestically without going overseas. Its domestic price is about three to four thousand yuan, but for specific prices and medical insurance reimbursement details, patients are advised to consult their local hospital pharmacy to obtain the most accurate information. On the other hand, if patients consider more economical options, foreign generic drug markets are also an alternative. In particular, the price of generic drugs on the market in Laos and Bangladesh is generally only about a few hundred yuan, which is far lower than the domestic price. It is worth mentioning that these generic drugs are basically the same as the original drugs in terms of drug ingredients, so they are also a treatment option worth considering.

Osimertinib/The mechanism of action of Osimertinib is mainly by inhibiting the EGFR signaling pathway, interfering with the growth, proliferation and survival of tumor cells, thereby inhibiting tumor development and metastasis. Compared with traditional chemotherapy drugs, Osimertinib/Osimertinib has a higher therapeutic effect and fewer toxic side effects, which can significantly extend the patient's survival time and improve the quality of life.

Osimertinib/Osimertinibis generally administered in the form of oral tablets, with a dose of 80 mg (mg) once a day. Patients on an empty stomach or after meals2To take it every hour, swallow the tablet whole and drink it with a sufficient amount of water (about 200ml). During treatment, doctors will adjust the dosage according to the patient's disease status and drug tolerance, and regularly conduct clinical evaluations, imaging examinations, and laboratory tests on patients to monitor treatment effects and adverse reactions.

In general, Osimertinib/Osimertinib, as a new type of targeted therapy, has important clinical significance for EGFRgene mutation-positive advanced NSCLC patients. Patients should follow the doctor's advice during medication and use Osimertinib correctly to improve the therapeutic effect and quality of life.